Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-201.26%
operating margin TTM
-204.04%
revenue TTM
82.67 Million
revenue per share TTM
1.31$
valuation ratios | |
|---|---|
| pe ratio | -11.95 |
| peg ratio | 7.32 |
| price to book ratio | 19.01 |
| price to sales ratio | 24.68 |
| enterprise value multiple | -13.81 |
| price fair value | 19.01 |
profitability ratios | |
|---|---|
| gross profit margin | 89.44% |
| operating profit margin | -204.04% |
| pretax profit margin | -199.98% |
| net profit margin | -201.26% |
| return on assets | -66.76% |
| return on equity | -378.61% |
| return on capital employed | -95.93% |
liquidity ratio | |
|---|---|
| current ratio | 3.24 |
| quick ratio | 3.08 |
| cash ratio | 0.77 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 497.96 |
| operating cycle | 549.88 |
| days of payables outstanding | 327.56 |
| cash conversion cycle | 222.32 |
| receivables turnover | 7.03 |
| payables turnover | 1.11 |
| inventory turnover | 0.73 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | -13.24 |
| cash flow to debt ratio | -28.92 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.85 |
| cash per share | 5.20 |
| operating cash flow per share | -1.85 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -28.92 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) reported earnings?
Rhythm Pharmaceuticals, Inc. (RYTM) published its most recent earnings results on 06-11-2024.
What is Rhythm Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)'s trailing twelve months ROE is -378.61%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Rhythm Pharmaceuticals, Inc. (RYTM) currently has a ROA of -66.76%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RYTM's net profit margin stand at?
RYTM reported a profit margin of -201.26% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RYTM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.24 in the most recent quarter. The quick ratio stood at 3.08, with a Debt/Eq ratio of 0.02.